News from the HMI

Upcoming publication:  Treatment End-stage Alzheimer’s Disease

NEW YORK (May 5, 2016) – Human Microbiology Institute is delighted to announce that its scientific core played a primary role in the groundbreaking study for the treatment of dementia in end-stage Alzheimer’s disease.

Novel species Bacillus sp VT-712 isolated from the intestine of a patient with duodenal cancer.

NEW YORK (April 30, 2016) – Human Microbiology Institute reports the complete genome sequence of novel species Bacillus sp VT-712 isolated from the intestine of a patient with duodenal cancer.

Human Microbiology Institute to Present at ASM Microbe 2016

NEW YORK (April 26, 2016) – Human Microbiology Institute a not-for-profit scientific research organization, today announced that George Tetz and Victor Tetz will present data for the research study “The Novel Species Paenibacillus sp. VT-400 as a Potentially Pathogenic Spore-Forming Bacteria in the Oral Cavity of Patients with Hematological Malignancies” at the ASM Microbe 2016 Conference (June 16–20, 2016, Boston, MA).

12